Related Experiment Videos
Pharmacokinetics of piperacillin in renal failure
The Medical Journal of Australia
|January 10, 1981
Abstract:
Patients with chronic renal failure who received bolus doses of piperacillin maintained high serum levels for up to six hours. The percentage of the injected dose which was detectable in the urine in 24 hours was reduced proportionately to the severity of the renal failure.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Key lessons from the COVID-19 public health response in Australia.
The Lancet regional health. Western Pacific·2022
[Neonatal presentation of Prader-Willi syndrome: A report of five cases].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017
Antibiotic resistance: are we all doomed?
Internal medicine journal·2015
Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
Not Gone but Often Forgotten: Action Needed to Address Tuberculosis in Aboriginal and Torres Strait Islander Communities.
The Medical journal of Australia·2026
Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.
The Medical journal of Australia·2026
Time for an Update: The Currency of Clinical Guidelines in Australia-A Cross-Sectional Analysis.
The Medical journal of Australia·2026
Forty Years in the Making: Reporting on the Co-Creation of a National Roadmap for Birthing on Country Services for the Best Start to Life.
The Medical journal of Australia·2026
Layered classification in Parkinson's disease: a content analysis of clinical, prodromal, and biological criteria evolution.
Frontiers in aging neuroscience·2026
Successful management of trichotillomania in a patient with SSRI-induced hypersomnia: a case report.
Frontiers in psychiatry·2026
Schiff Bases as Multifunctional Agents in Parkinson's Disease Therapy: A Comprehensive Review.
Mini reviews in medicinal chemistry·2026
In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist.
Xenobiotica; the fate of foreign compounds in biological systems·2026
Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.
Clinical pharmacology and therapeutics·2026
From Pathogenesis to Therapy: Extracellular Vesicles Orchestrate Cellular Crosstalk in Acetaminophen Hepatotoxicity.
European journal of pharmacology·2026